| 04/22/2026 6:49 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/21/2026 3:05 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/20/2026 3:28 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 8:30 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 5:02 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/13/2026 3:01 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/09/2026 8:26 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/08/2026 8:23 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/07/2026 5:27 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 6:14 PM | Smith Darren Charlton (2122447) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 6:25 AM | Smith Darren Charlton (2122447) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for TLPPF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/01/2026 6:25 AM | Cade David Norman (2123007) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 6:24 AM | Patti Darren Joel (2122492) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 6:24 AM | Nelson Mark Alexander (1352919) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/20/2026 3:06 PM | Telix Pharmaceuticals (2007191) Filer | Form 20-F/A | |
| 03/18/2026 7:45 PM | Behrenbruch Christian (2037713) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:47 PM | Skinner Jann Elizabeth (2121838) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:48 PM | McDonald Marie Elizabeth (2120369) Reporting Telix Pharmaceuticals (2007191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/16/2026 4:00 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/20/2026 5:09 AM | Telix Pharmaceuticals (2007191) Filer | Form F-3ASR | |
| 02/19/2026 7:44 PM | Telix Pharmaceuticals (2007191) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/19/2026 4:22 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/18/2026 8:12 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/02/2026 7:50 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/20/2026 3:15 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 3:07 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 5:52 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/17/2025 3:06 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/08/2025 3:08 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/14/2025 7:36 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/23/2025 3:21 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/28/2025 3:09 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/20/2025 7:39 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/22/2025 7:25 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/09/2025 6:44 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/11/2025 4:09 PM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/21/2025 7:39 AM | Telix Pharmaceuticals (2007191) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |